Video Clips

Quoted moments from Alaska public meetings, hearings, and press conferences.

1:06

Bill Cassidy

The Insulin Act, sponsored by Senators Collins and Shaheen, caps how much patients pay for insulin, preserving access for the 40 million Americans with diabetes.

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

1:01

Susan Collins

I am concerned that his bill will not truly combat diabetes. That's why the diabetes advocacy groups have not taken a position on this bill. But it will have the unintended consequence of making food more expensive for Americans.

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

0:31

Susan Collins

I support this amendment and pleased to be the principal co-sponsor. The original bill that we reintroduced in this Congress had this provision in it in an attempt to move the bill along. We agreed to take it out and decide it at the committee level. But I think it's important that we not leave this population, the most vulnerable population, behind.

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

0:56

Bill Cassidy

The Patients Deserve Price Tags Act, championed by Senators Marshall and Hickenlooper, will make pricing information more easily available, empowering patients to compare prices and to pick the highest quality affordable option for care.

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

0:37

Bill Cassidy

we're also marking up Senator Sanders' Childhood Diabetes Reduction Act. This bill increases transparency for families around ultra-processed food and restricts targeting of junk food ads towards kids.

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

0:54

Tammy Baldwin

This bipartisan amendment would restore a pilot program for uninsured patients to access insulin for $35 a month and a resource center to help patients afford and access affordable insulin. Both of these policies were in the original text of the Insulin Act, but unfortunately are not in the manager's amendment before us today.

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

0:50

Susan Collins

Maine continues to face a serious shortage of nurses, particularly in our rural communities where hospitals struggle to recruit and retain staff. This shortage is driven by a severe shortage of nursing faculty. Our bill would help to strengthen the nursing workforce by reauthorizing critical programs that support nursing education, expand access to clinical training, and help schools prepare more students for careers in nursing.

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

0:48

Larry McNeil

AI is kind of like this drunken car, you know, going 200 miles an hour, you know, down a busy street, and there's no guardrails or very little guardrails. And that's the scary part.

Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

0:19

Larry McNeil

It's balance and AI can't do that. Thank you, Dorothy. Yes, I would totally agree with that. I don't think AI has the ability to really do maybe what we could call is a proper form line. At least I haven't seen it yet.

Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

1:01

Larry McNeil

This points to an ethics weakness that are starting to appear with the usage of AI as a systemic tool, especially when humans are removed from hiring decisions.

Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

0:31

Larry McNeil

I'm going to talk about the artist statement just really briefly. It's what you need to author yourself because authenticity is an important aspect of all of it.

Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

0:32

Larry McNeil

in the age of artificial intelligence, artists need to be more innovative with making a living as artists. We need to be innovative and reassert the authenticity of our art in the face of AI.

Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

0:19

Kelly Monteleone

What about our form line art, and how is AI a threat to copy or redefine the art form? The artist can manipulate form line by 1/16 of an inch and it matters.

Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

0:43

Trevor Storrs

$480,000 is basically 20% of what was available. So we're actually decreasing things by 80% in that category.

Anchorage Assembly: ACCEE Fund Board Meeting 2026-07-15 Meeting Recording · Jul 21, 2026

0:26

Trevor Storrs

operational grants, were at $2.4 million, and then pilot this year was just, was at one, how many, $1.1 million. Christina? 1.25.

Anchorage Assembly: ACCEE Fund Board Meeting 2026-07-15 Meeting Recording · Jul 21, 2026